Mutations affecting beta-tubulin folding and degradation
Yaqing Wang1, Guoling Tian2, Nicholas J Cowan2
1Department of Integrative Biology and Pharmacology, The University of Texas Medical School, Houston, Texas 77030.
Abstract:
Revertants of a colcemid-resistant Chinese hamster ovary cell line with an altered (D45Y) beta-tubulin have allowed the identification of four cis-acting mutations (L187R, Y398C, a 12-amino acid in-frame deletion, and a C-terminal truncation) that act by destabilizing the mutant tubulin and preventing it from incorporating into microtubules. These unstable beta-tubulins fail to form heterodimers and are predominantly found in association with the chaperonin CCT, suggesting that they cannot undergo productive folding. In agreement with these in vivo observations, we show that the defective beta-tubulins do not stably interact with cofactors involved in the tubulin folding pathway and, hence, fail to exchange with beta-tubulin in purified alphabeta heterodimers. Treatment of cells with MG132 causes an accumulation of the aberrant tubulins, indicating that improperly folded beta-tubulin is degraded by the proteasome. Rapid degradation of the mutant tubulin does not elicit compensatory changes in wild-type tubulin synthesis or assembly. Instead, loss of beta-tubulin from the mutant allele causes a 30-40% decrease in cellular tubulin content with no obvious effect on cell growth or survival.
Insights
Scientists identified mutations that destabilize mutant beta-tubulin, preventing microtubule incorporation. This leads to proteasomal degradation and reduced cellular tubulin without affecting cell growth.
Area of Science:
- Cell Biology
- Molecular Biology
- Protein Folding and Degradation
Background:
- Beta-tubulin is a critical component of microtubules, essential for cell structure and division.
- Mutations in beta-tubulin can lead to altered protein stability and function.
- Cellular mechanisms, including chaperones and proteasomes, regulate protein folding and degradation.
Purpose of the Study:
- To identify cis-acting mutations that destabilize a colcemid-resistant mutant beta-tubulin (D45Y).
- To investigate the folding, assembly, and degradation pathways of these destabilized mutant beta-tubulins.
- To understand the cellular consequences of reduced beta-tubulin levels due to mutant protein instability.
Main Methods:
- Analysis of revertants from a colcemid-resistant Chinese hamster ovary cell line.
- Identification of cis-acting mutations affecting mutant beta-tubulin stability.
- In vivo and in vitro assays to assess tubulin folding, heterodimerization, and proteasomal degradation (using MG132).
- Measurement of cellular tubulin content and assessment of cell growth and survival.
Main Results:
- Four cis-acting mutations (L187R, Y398C, deletion, truncation) were identified that destabilize mutant beta-tubulin.
- Destabilized beta-tubulins fail to form heterodimers, associate with chaperonin CCT, and do not interact with folding cofactors.
- Improperly folded beta-tubulin is degraded by the proteasome, leading to a 30-40% decrease in total cellular tubulin.
- Reduced tubulin content does not impact cell growth or survival.
Conclusions:
- Specific mutations can render mutant beta-tubulin unstable, leading to its failure in productive folding and microtubule incorporation.
- The proteasome efficiently degrades misfolded beta-tubulin, preventing its accumulation.
- Cells can tolerate significant reductions in beta-tubulin levels without compromising viability or growth, suggesting robust cellular regulation.
More Related Videos
07:21Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues
Published on: November 17, 2023
08:02Extracting Modified Microtubules from Mammalian Cells to Study Microtubule-Protein Complexes by Cryo-Electron Microscopy
Published on: March 3, 2023
Related Concept Videos
Destabilization of Microtubules
Microtubule Instability
Drugs that Stabilize Microtubules
Bacterial Protein Maturation
Drugs that Destabilize Microtubules
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
